Tobias Thornblad is the CEO at Dermafol a Gothenburg based company that develops treatments for oral and skin diseases. He is also co-founder of Monocl, a Life Science Intelligence company guiding investors and business leaders to make informed investment decisions. Tobias has previously worked as a consultant at CIP Professional Services AB and at the Center for Intellectual Property (CIP), where he specialized in the biotech field. Recent work at CIP includes a peer-reviewed paper Tobias cowrote on the role of intellectual property platforms within Life Science. Prior to his position at CIP Professional Services, he held an Intellectual Capital Management position at Dow AgroSciences (a fully-owned subsidiary of the Dow Chemical Company), Indianapolis, USA. He has two master degrees in Intellectual Capital Management and Bioengineering, both from the Swedish Chalmers University of Technology, in addition to a diploma in Biotechnology and Business from Queensland University of Technology, Australia.